kinase inhibitors (ArQule)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namekinase inhibitors (ArQule)
Drug Alias NameLO-03
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAnticancer protein kinase inhibitors
TargetsUpdating
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArqule Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArqule Inc
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell Lung

Other Information

ATC CodeN/A
Related LinksN/A